Trial NCT04705051

View at ClinicalTrials.gov 
Org. Study IDs: LTS15823
Secondary IDs: 2020-004400-34 U1111-1256-8805

Last trial update was posted on 2022-10-06

MeSH Interventions

Venglustat

MeSH Conditions

Kidney Diseases Kidney Diseases, Cystic Polycystic Kidney Diseases Polycystic Kidney, Autosomal Dominant

Other Conditions

Congenital Cystic Kidney Disease

Stopping Reasons

LTS15823 (long-term extension of the EFC15392 study) was stopped after protocol specified interim analysis for futility of the parent EFC15392 study met the prespecified stopping rule based on the primary outcome measure.

Limitations And Caveats

The study was terminated prematurely by the Sponsor following a decision to terminate the parent study EFC15392. Termination decision was due to lack of efficacy in ADPKD population and not linked to safety findings with venglustat.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID